| Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition TR Arkell, N Lintzeris, RC Kevin, JG Ramaekers, R Vandrey, C Irwin, ... Psychopharmacology 236, 2713-2724, 2019 | 174 | 2019 |
| Effect of cannabidiol and Δ9-tetrahydrocannabinol on driving performance: a randomized clinical trial TR Arkell, F Vinckenbosch, RC Kevin, EL Theunissen, IS McGregor, ... Jama 324 (21), 2177-2186, 2020 | 128 | 2020 |
| Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review D McCartney, TR Arkell, C Irwin, IS McGregor Neuroscience & Biobehavioral Reviews 126, 175-193, 2021 | 117 | 2021 |
| Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) N Lintzeris, L Mills, A Suraev, M Bravo, T Arkell, JC Arnold, MJ Benson, ... Harm reduction journal 17, 1-12, 2020 | 96 | 2020 |
| Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices TR Arkell, RC Kevin, J Stuart, N Lintzeris, PS Haber, JG Ramaekers, ... Drug testing and analysis 11 (10), 1486-1497, 2019 | 46 | 2019 |
| The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study TR Arkell, TR Spindle, RC Kevin, R Vandrey, IS McGregor Traffic injury prevention 22 (2), 102-107, 2021 | 41 | 2021 |
| Driving-related behaviours, attitudes and perceptions among Australian medical cannabis users: results from the CAMS 18-19 survey TR Arkell, N Lintzeris, L Mills, A Suraev, JC Arnold, IS McGregor Accident Analysis & Prevention 148, 105784, 2020 | 34 | 2020 |
| Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials TR Arkell, RC Kevin, F Vinckenbosch, N Lintzeris, E Theunissen, ... Addiction biology 27 (2), e13125, 2022 | 25 | 2022 |
| Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis D McCartney, TR Arkell, C Irwin, RC Kevin, IS McGregor Neuroscience & Biobehavioral Reviews 134, 104433, 2022 | 23 | 2022 |
| Medical cannabis and driving TR Arkell, D McCartney, IS McGregor Australian journal of general practice 50 (6), 357-362, 2021 | 23 | 2021 |
| The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol D McCartney, MJ Benson, AS Suraev, C Irwin, TR Arkell, RR Grunstein, ... Human Psychopharmacology: Clinical and Experimental 35 (5), e2749, 2020 | 20 | 2020 |
| Assessment of medical cannabis and health-related quality of life TR Arkell, LA Downey, AC Hayley, S Roth JAMA network open 6 (5), e2312522-e2312522, 2023 | 10 | 2023 |
| Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis NRPW Hutten, TR Arkell, F Vinckenbosch, J Schepers, RC Kevin, ... Psychopharmacology 239 (11), 3731-3741, 2022 | 7 | 2022 |
| Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol DJ Allsop, K Rooney, JC Arnold, AK Bhardwaj, R Bruno, DJ Bartlett, ... Mental Health and Physical Activity 13, 57-67, 2017 | 7 | 2017 |
| & McGregor, IS (2019). Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition TR Arkell, N Lintzeris, RC Kevin, JG Ramaekers, R Vandrey, C Irwin Psychopharmacology 236 (9), 2713-2724, 0 | 7 | |
| Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials TR Arkell, K Bradshaw, LA Downey, AC Hayley Addiction biology 27 (2), e13128, 2022 | 6 | 2022 |
| The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial D McCartney, AD Isik, K Rooney, JC Arnold, DJ Bartlett, B Murnion, ... Journal of Sleep Research 30 (3), e13211, 2021 | 6 | 2021 |
| High standards: considerations for the application of the standard THC unit TR Arkell, AC Hayley, LA Downey The Lancet Psychiatry 8 (11), 947-948, 2021 | 5 | 2021 |
| Managing the high: developing legislation and detection methods for cannabis impairment TR Arkell, AC Hayley, LA Downey Nature Reviews Neuroscience 22 (9), 584-584, 2021 | 5 | 2021 |
| Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review TR Arkell, A Brooks-Russell, LA Downey, B Shiferaw, T Brown, J Sherrick, ... Neuroscience & Biobehavioral Reviews 141, 104831, 2022 | 4 | 2022 |
